Study S000661

Pilot Study of the GLP-1 Agonist, Liraglutide, on Decreasing Parenteral Support Requirements in Short Bowel Patients.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03371862
Acronym: SLIPS
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2017-10-20
Primary completion: 2020-08-06
Lead sponsor: Imperial College London
Conditions: Short Bowel Syndrome
Interventions: DRUG:Liraglutide Pen Injector [Victoza]
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Improvement in parenteral support [20 weeks post start of drug]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.